JP2010518173A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010518173A5 JP2010518173A5 JP2009549760A JP2009549760A JP2010518173A5 JP 2010518173 A5 JP2010518173 A5 JP 2010518173A5 JP 2009549760 A JP2009549760 A JP 2009549760A JP 2009549760 A JP2009549760 A JP 2009549760A JP 2010518173 A5 JP2010518173 A5 JP 2010518173A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- cancer
- salts
- group
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100375572A CN101245050A (zh) | 2007-02-14 | 2007-02-14 | 4-苯胺喹唑啉衍生物的盐 |
| CN200710037557.2 | 2007-02-14 | ||
| PCT/CN2008/000318 WO2008098485A1 (en) | 2007-02-14 | 2008-02-04 | The salts of 4-aniline quinazoline derivative |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010518173A JP2010518173A (ja) | 2010-05-27 |
| JP2010518173A5 true JP2010518173A5 (OSRAM) | 2011-04-07 |
| JP5504460B2 JP5504460B2 (ja) | 2014-05-28 |
Family
ID=39689656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009549760A Active JP5504460B2 (ja) | 2007-02-14 | 2008-02-04 | ４−フェニルアミノキナゾリン誘導体の塩形態 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8349854B2 (OSRAM) |
| EP (1) | EP2116540B1 (OSRAM) |
| JP (1) | JP5504460B2 (OSRAM) |
| KR (1) | KR20100014947A (OSRAM) |
| CN (3) | CN101245050A (OSRAM) |
| AU (1) | AU2008215053B2 (OSRAM) |
| CA (1) | CA2677978C (OSRAM) |
| WO (1) | WO2008098485A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101347433B (zh) * | 2007-07-20 | 2012-05-02 | 江苏艾力斯生物医药有限公司 | 4-苯胺喹唑啉衍生物的制药用途 |
| CN101544609A (zh) * | 2008-03-25 | 2009-09-30 | 上海艾力斯医药科技有限公司 | 4-苯胺喹唑啉衍生物的结晶形式 |
| CN101584696A (zh) | 2008-05-21 | 2009-11-25 | 上海艾力斯医药科技有限公司 | 包含喹唑啉衍生物的组合物及制备方法、用途 |
| CN108430972B (zh) | 2015-12-24 | 2022-12-27 | 协和麒麟株式会社 | α,β不饱和酰胺化合物 |
| CN106117182B (zh) * | 2016-06-20 | 2019-08-30 | 中国药科大学 | 喹唑啉-n-苯乙基四氢异喹啉类化合物及其制备方法和应用 |
| CN112225679A (zh) * | 2020-10-13 | 2021-01-15 | 苏州亚科科技股份有限公司 | 一种3-(环己胺)-2-羟基-1-丙磺酸的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
| AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
| GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
| GB9510757D0 (en) * | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| EP1110953B1 (en) | 1995-03-30 | 2009-10-28 | Pfizer Products Inc. | Quinazoline derivatives |
| RO121900B1 (ro) | 1996-04-12 | 2008-07-30 | Warner-Lambert Company | Compuşi inhibitori, ireversibili, ai tirozin kinazelor, compoziţie farmaceutică care îi conţine şi utilizarea acestora |
| GB9800575D0 (en) * | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
| GB9800569D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
| TW533204B (en) | 1998-07-30 | 2003-05-21 | Wyeth Corp | A process for preparing substituted quinazoline derivatives |
| CZ300945B6 (cs) * | 2000-06-30 | 2009-09-23 | Glaxo Group Limited | Zpusob prípravy 5-(6-chinazolinyl)-furan-2-karbaldehydu |
| KR100735639B1 (ko) * | 2004-12-29 | 2007-07-04 | 한미약품 주식회사 | 암세포 성장 억제 효과를 갖는 퀴나졸린 유도체 및 이의제조방법 |
| CN101003514A (zh) * | 2006-01-20 | 2007-07-25 | 上海艾力斯医药科技有限公司 | 喹唑啉衍生物、其制备方法及用途 |
-
2007
- 2007-02-14 CN CNA2007100375572A patent/CN101245050A/zh active Pending
-
2008
- 2008-02-04 CN CN201510098689.0A patent/CN104628658B/zh active Active
- 2008-02-04 AU AU2008215053A patent/AU2008215053B2/en active Active
- 2008-02-04 WO PCT/CN2008/000318 patent/WO2008098485A1/zh not_active Ceased
- 2008-02-04 EP EP08706496.0A patent/EP2116540B1/en active Active
- 2008-02-04 CN CN200880005090A patent/CN101668750A/zh active Pending
- 2008-02-04 JP JP2009549760A patent/JP5504460B2/ja active Active
- 2008-02-04 KR KR1020097018740A patent/KR20100014947A/ko not_active Ceased
- 2008-02-04 US US12/527,345 patent/US8349854B2/en active Active
- 2008-02-04 CA CA2677978A patent/CA2677978C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010518173A5 (OSRAM) | ||
| JP2018188432A5 (OSRAM) | ||
| JP2011500717A5 (OSRAM) | ||
| JP2020521754A5 (OSRAM) | ||
| JP2018065876A (ja) | ニロチニブと選択された共結晶体を含有する多成分結晶系 | |
| JP2012504628A5 (OSRAM) | ||
| RU2734260C2 (ru) | Применение производных хинолина для лечения рака пищевода, а также способ лечения, фармацевтическая композиция и набор с их использованием | |
| JP2012526766A5 (OSRAM) | ||
| CN103709122B (zh) | 用于治疗的抗肿瘤和抗真菌化合物 | |
| CN105541876B (zh) | 蒽醌桥联的氮杂环卡宾金属配合物及其制备方法与应用 | |
| JPWO2021097207A5 (OSRAM) | ||
| JP2011515421A5 (OSRAM) | ||
| CN103980882B (zh) | 含氮元素阳离子发色团及其制备 | |
| WO2022111448A1 (zh) | 一种btk降解剂的制备方法 | |
| CN102993181A (zh) | 埃索美拉唑的制备方法及埃索美拉唑盐的制备方法 | |
| CN111423446A (zh) | 具有光、声敏活性的二氢卟吩硝酸酯类化合物、制备方法与应用 | |
| ES2668470T3 (es) | Compuestos de platino para tratar enfermedades de proliferación celular, procedimientos de preparación y usos de los mismos | |
| CN103570790B (zh) | 原人参二醇衍生物及其制备方法、包含该衍生物的组合物及其用途 | |
| CN105669567A (zh) | 一种酪氨酸激酶抑制剂及其制备方法和用途 | |
| WO2023221828A1 (zh) | 一种倍半萜衍生物、其药物组合物及其制备方法和用途 | |
| CN116554158A (zh) | 一种异吲哚啉基-哌嗪基脲类化合物、其制备方法及应用 | |
| CN103864630B (zh) | (s)-1-(4-乙氧基苄基)-3-氮杂戊烷-1,5-二胺三盐酸盐的合成方法 | |
| JP2005536464A5 (OSRAM) | ||
| JP2005529920A5 (OSRAM) | ||
| CN103396361B (zh) | 3,4-二氢异喹啉类抗肿瘤化合物及其制备方法与应用 |